在心力衰竭患者中,可溶性ST2度与营养状况之间的相关性与减少喷射分数 - 横截面研究
Marta Kałużna-Oleksy1, Filip Waśniewski2, Magdalena Szczechla2
11st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland. marta.kaluzna@wp.pl.
Cardiology journal
|May 14, 2024
概括
瘤发生率-2 (sST2) 水平的可溶性抑制与心力衰竭患者的营养状况较差相关. 这一发现可以指导HFrEF个体的营养干预措施.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 营养科学 营养科学
背景情况:
- 心力衰竭 (HF) 是一个全球性的健康问题,死亡率很高.
- 瘤发生性-2 (sST2) 的可溶性抑制,一种介素-33受体,与增加HF死亡率有关.
- 肝炎患者的营养不良与炎症和更差的预后有关.
研究的目的:
- 调查心力衰竭患者的sST2度和营养状况之间的关联,减少喷射分数 (HFrEF).
主要方法:
- 一项横截面研究包括138名HFrEF患者.
- 用老年营养风险指数 (GNRI) 和控制营养状况 (CONUT) 评分来评估营养状况.
- 患者的平均年龄为53.6±10.8岁.
主要成果:
- 患有较高sST2水平 (> 32.9 ng/mL) 的患者表现出更高的GNRI得分和更高的营养不良风险 (29%对12%) 的患病率.
- 在较高的sST2组 (2对1),中位数CONUT得分更差,营养不良的风险更普遍.
- 这些关联仍然是显著的,并且独立于天然尿素,年龄和性别.
结论:
- 这项研究是首次证明HFrEF患者sST2度与营养状况之间的关系.
- 升高的sST2可能表明对营养评估和HFrEF干预的需求增加.
- sST2可以作为一种有价值的生物标志物,用于识别需要营养支持的HFrEF患者.
关键词:
这就是HFrEFEF.ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2生物标志物 生物标志物心脏衰竭是因为心脏衰竭.营养不良 营养不良 营养不良营养状态 营养状况抑制瘤发生性-2-2更多相关视频
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
5.8K
06:39Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
14.9K
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
80
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
80
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
141
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
141